Zurcher Kantonalbank (Zurich Cantonalbank) Cure Vac N.V. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Cure Vac N.V. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 25,477 shares of CVAC stock, worth $83,564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,477
Previous 25,477
-0.0%
Holding current value
$83,564
Previous $74,000
16.22%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CVAC
# of Institutions
86Shares Held
10.5MCall Options Held
75.5KPut Options Held
33.5K-
Black Rock Inc. New York, NY2.25MShares$7.39 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.65MShares$5.4 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$5.15 Million10.6% of portfolio
-
Ubs Group Ag577KShares$1.89 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$1.64 Million0.01% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $615M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...